Skip to content

Expiratory pressure for severe acute respiratory distress syndrome with V-V ECMO respiratory support trial

Comparison of positive end-expiratory pressure for severe acute respiratory distress syndrome with V-V ECMO respiratory support: ExPress SAVEr trial - ExPress SAVER trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1062220062
Enrollment
210
Registered
2022-10-05
Start date
2022-10-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome ARDS, acute respiratory distress syndrome, ECMO, extracorporeal membrane oxygenation

Interventions

Eligible participants were randomly assigned to the high PEEP group or low PEEP group. High PEEP group PEEP are set to 15 cm H2O from the start of V-V ECMO support until the liberation trial from V-V
D011175
PEEP, positive end-expiratory pressure, mechanical ventilation

Sponsors

Ohshimo Shinichiro
Lead Sponsor
Nishikimi Mitsuaki
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients (18-80 years old) with ARDS requiring V-V ECMO

Exclusion criteria

Exclusion criteria: 1. Had been converted from V-A ECMO 2. Had been on a ventilator for longer than 7 days 3. Hemodynamically unstable with LVEF below 40 percent 4. Pneumothorax or air leak syndrome 5. ARDS due to thoracic trauma 6. ARDS due to extra-pulmonary reason 7. Known pregnancy 8. Were judged by the ICU attending doctors as being unsuitable to participate in this study based on their medical condition

Design outcomes

Primary

MeasureTime frame
ECMO-free days during the first 28 days

Secondary

MeasureTime frame
mortality at 28 days, in-hospital mortality at 60 days, ventilator-free days during the first 60 days, length of ICU stay

Contacts

Public ContactMitsuaki Nishikimi

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University

m0528332626@yahoo.co.jp+81-82-257-5456

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026